Aphria: Jefferies Upgrades Tilray On EU, US Prospects
The merger between Tilray Inc (NASDAQ: TLRY) and Aphria was a "perfect match" and the entity could generate pro-forma sales growth of 33% between fiscal 2021 and 2024, according to Jefferies.
Read full article »
Aphria owns and operates a number of cannabis brands that provides marijuana and alternative medicine products to pharmaceutical industries.
Read more